{
    "title": "Roche Q1 sales decline tempered by swift uptake of new eye drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12014721/Roche-Q1-sales-7-COVID-related-business-wanes.html",
    "date": "2023-04-26",
    "keywords": [
        "vabysmo",
        "roche",
        "growth",
        "treatment",
        "market",
        "view",
        "consensus",
        "singledigit",
        "manager",
        "burger",
        "revenue",
        "eye",
        "drug",
        "company",
        "quarter",
        "ronapreve",
        "year",
        "bayer",
        "regeneron",
        "q1",
        "mln",
        "core",
        "range",
        "fund",
        "comment",
        "demand",
        "covid19",
        "group",
        "wednesday",
        "launch",
        "antibody",
        "actemra",
        "injection",
        "form",
        "blindness",
        "approval",
        "driver",
        "division",
        "thomas",
        "schinecker",
        "head",
        "job",
        "march",
        "uptake",
        "world",
        "call",
        "challenger",
        "product",
        "degeneration",
        "macula",
        "back",
        "alliance",
        "eylea",
        "version",
        "shot",
        "advantage",
        "gmt",
        "concern",
        "performance",
        "pharma",
        "terence",
        "mcmanus",
        "portfolio",
        "bellevue",
        "asset",
        "management",
        "kuesnacht",
        "switzerland",
        "element",
        "beat",
        "time",
        "covid",
        "share",
        "percentage",
        "reporting",
        "kirsti",
        "heine",
        "sharon",
        "singleton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}